Ovarian stimulation for in vitro fertilization in patients with endometriosis

Kostantinos Zikopoulos, Zikopoulos K, Efstratios M. Kolibianakis, Efstratios M. Κolibianakis, Devroey P, Paul Devroey
Acta obstetricia et gynecologica Scandinavica · 2004 · vol. 83(7) , pp. 651–655 · doi:10.1111/j.0001-6349.2004.00543.x · PMID:15225190 · W2084023444
review OA: closed CC0 ⤵ 19 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-11 ⓘ

This study investigated the use of GnRH agonists and antagonists for ovarian stimulation in patients with endometriosis undergoing IVF, noting potential benefits of prolonged downregulation with GnRH agonists.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The use of gonadotropin-releasing hormone (GnRH) agonists in a long protocol appears to enhance the probability of conception in the presence of endometriosis. In addition, there is evidence to suggest that the use of prolonged downregulation with GnRH agonists prior to ovarian stimulation for in vitro fertilization (IVF) is beneficial for achieving pregnancy. Until now, GnRH antagonists have not been used in patients with endometriosis. The management of endometriomas prior to stimulation for IVF and its impact on reproductive outcome are still subject to debate.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Fertility Agents, Female Fertilization in Vitro Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Infertility, Female Adult Endometriosis Female Fertility Agents, Female Fertility Agents, Female Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Humans Infertility, Female Infertility, Female Ovulation Induction Pregnancy Pregnancy Outcome

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (36)

Cited by (19)

Source provenance

europepmc
last seen: 2026-08-25T06:10:03.373225+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:12:32.173627+00:00
unpaywall
last seen: 2026-08-25T06:41:39.333708+00:00
License: CC0 · commercial use OK